957 A RANDOMIZED CONTROLLED TRIAL EVALUATING THE EFFECT OF ENVIRONMENTAL RICHNESS ON GASTROINTESTINAL SYMPTOMS, SALIVARY CORTISOL, AND GUT MICROBIOTA IN EARLY CHILDHOOD
Leggi →
Maggio 2024
Risultati per: È confermato il legame tra la malattia di Alzheimer e microbiota intestinale
Questo è quello che abbiamo trovato per te
913 THE BILE ACIDS METABOLITES PRODUCED BY THE INTESTINAL MICROBIOTA ACT AS GPBAR1 AGONIST AND RORΓT INVERSE AGONIST DETERMINING THE COURSE OF INFLAMMATORY BOWEL DISEASE
Leggi →
Maggio 2024
533 REGIONAL MICROBIOTA MISMATCHES FROM FECAL MICROBIOTA TRANSPLANTS DRIVE PERSISTENT, OFF-TARGET CONSEQUENCES TO THE HOST
Leggi →
Maggio 2024
693 ACUTE CENTRAL STRESS DAMAGE THE COLONOCYTE MITOCHONDRIA AND DISTURB MICROBIOTA COMMUNITY VIA CRHR1
Leggi →
Maggio 2024
625 MUCOSAL ENTERIC GLIA RELEASE CILIARY NEUROTROPHIC FACTOR (CNTF) TO MAINTAIN THE HOMEOSTASIS OF ENTERIC NEURAL CIRCUITS BY AN INDIGENOUS GUT-MICROBIOTA DRIVEN CONSTITUTIVE MECHANISM
Leggi →
Maggio 2024
494 ORAL SODIUM BUTYRATE ADMINISTRATION SIGNIFICANTLY IMPROVES CLINICAL OUTCOME AND QUALITY OF LIFE IN PATIENTS WITH CROHN'S DISEASE BY MODIFYING THE GUT MICROBIOTA – RESULTS FROM A RANDOMISED PLACEBO-CONTROLLED STUDY
Leggi →
Maggio 2024
400 VITAMIN D DIFFERENTIALLY REGULATES MUCOSAL IMMUNOGLOBULIN BINDING TO GUT MICROBIOTA AND DENDRITIC CELL-B CELL SIGNALING IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
Leggi →
Maggio 2024
731 FAECAL MICROBIOTA TRANSPLANTATION IN ACTIVE ULCERATIVE COLITIS: INSIGHTS FROM A RANDOMIZED CONTROLLED TRIAL HALTED FOR FUTILITY
Leggi →
Maggio 2024
715 THE EFFECT OF GUT MICROBIOTA ON IMMUNE CHECKPOINT INHIBITORS IN THE TREATMENT OF PAN-CANCER AND NOVEL MICROBIAL BIOMARKERS FOR PREDICTING THERAPEUTIC RESPONSE
Leggi →
Maggio 2024
Sa1527 RECURRENCE OF PRIMARY SCLEROSING CHOLANGITIS AFTER LIVER TRANSPLANTATION IS CHARACTERIZED BY A DISTINCT GUT MICROBIOTA PROFILE
Leggi →
Maggio 2024
Tu1921 EVALUATION OF INTESTINAL MICROBIOTA COMPOSITION PRE- AND POST ENDOSCOPIC SLEEVE GASTROPLASTY: A PROSPECTIVE OBSERVATIONAL COHORT STUDY
Leggi →
Maggio 2024
Tu1916 LABTHERA-002, A LIVE BIOTHERAPEUTIC PRODUCT, IMPROVES THE FOLFOX-INDUCED CACHEXIA IN COLORECTAL CANCER MICE MODEL THROUGH GUT MICROBIOTA MODULATION.
Leggi →
Maggio 2024
Mo1928 THE ROLE OF GUT MICROBIOTA AND INNATE IMMUNE RESPONSE IN AN AUTOIMMUNE PANCREATITIS MODEL
Leggi →
Maggio 2024
Mo1916 FECAL MICROBIOTA TRANSPLANTATION FORMULATION DO NOT AFFECT BACTERIAL VIABILITY OR TREATMENT OUTCOMES IN RECURRENT C DIFFICILE INFECTION
Leggi →
Maggio 2024
Tu1657 EFFECT OF MICROBIOTA MODULATION WITH RIFAXIMIN IN THE SEVERITY OF FIBROMYALGIA SYMPTOMS, IN PATIENTS WITH AND WITHOUT IBS. AN EXPLORATORY BEFORE AND AFTER STUDY
Leggi →
Maggio 2024
Mo1726 REDUCED POLYPHENOL DEGRADATION IN CROHN'S DISEASE PATIENTS’ GUT MICROBIOTA
Leggi →
Maggio 2024
